Patent · US Active

Anti-PD-L1 antibodies

US10435470B2 · kind B2 · utility

7Cited by
61References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2015
Grant dateOct 8, 2019
Priority date—
Expiry dateSep 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to antibodies and antigen-binding fragments thereof that bind to PD-L1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-L1 antibodies and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.